29.5 C
Vientiane
Wednesday, June 18, 2025
spot_img
Home Blog Page 69

How clean energy fuels the comeback of Shennongjia’s golden snub-nosed monkeys?

BEIJING, May 29, 2025 /PRNewswire/ — Finding Answers in China from China.org.cn:


How clean energy fuels the comeback of Shennongjia’s golden snub-nosed monkeys?

Deep in the lush and mysterious forests of Shennongjia, central China’s Hubei province, golden figures leap effortlessly through the treetops—these are the Shennongjia golden snub-nosed monkeys. Once on the brink of extinction, they’ve made a stunning recovery and are now even recognized as a unique subspecies. But what’s the story behind their stunning revitalization? How has China’s energy transition played a key role in protecting their habitat? And can China’s ecological wisdom offer new solutions for the world?

To find out, Peruvian host Rebeca Phang from China.org.cn teams up with global energy expert Professor Saifur Rahman for a journey into the heart of Shennongjia.

When clean energy meets biodiversity conservation, and when technology empowers nature to thrive, the answers may lie in the rhythm of the forest—and in China’s commitment to green development. This is more than a story about endangered monkeys; it’s a search for a new path to harmony between humanity and nature.

How clean energy fuels the comeback of Shennongjia’s golden snub-nosed monkeys?
https://youtu.be/Wj1Hd2OaZhE

MinIO AIStor Sets New Standard for AI and Data-Intensive Workloads with Industry-First AWS S3 Express API Support

Enterprise object storage with built-in replication brings S3 Express API performance to the entire data lakehouse, at no extra cost

REDWOOD CITY, Calif., May 29, 2025 /PRNewswire/ — MinIO, the leader in high-performance object storage for the exabyte AI era, today announced AIStor support for Amazon’s S3 Express API, a streamlined version of the general-purpose S3 API designed to deliver maximum performance for AI and data-intensive analytics workloads. MinIO AIStor is the first and only AI data storage platform to adopt Amazon’s S3 Express API and enable organizations to put all of their analytical and AI data, not just a subset, in “express mode” at no extra cost.

Introduced by AWS in 2023 and delivered via the Amazon S3 Express One Zone storage class, the Amazon S3 Express API has defined a new industry standard for high performance and developer-friendly AI and analytics storage, delivering 10x faster performance compared to the S3 Standard storage class. But, in AWS, the enhanced performance of AWS S3 Express One Zone comes at over five times the cost of S3 Standard to store data and doesn’t come with data protection and replication capabilities. Consequently, to use it safely, customers must save a durable copy of their data in S3 standard and copy data that requires high speed access into S3 Express One Zone.

With this release, MinIO is democratizing access to and use of this powerful API for all data processing needs by coupling its dramatic performance advantages with full active/passive, disaster recovery (DR), and batch replication support, all at no extra cost. Enterprises can continue leveraging the general purpose S3 API for raw source data requiring versioning and immutability before any processing, but can now leverage the high performance S3 Express API for all other downstream workloads and derived data sets, especially, but not limited to, high intensity data processing. This includes the majority of data lakehouse analytics with Apache Spark and Iceberg, AI data pre-processing, and AI model training and inference.

“Until now, use of S3 Express has typically been reserved for data that requires high speed access at the expense of enterprise features like replication and lifecycle management, due to its cost premium over S3 Standard,” said Garima Kapoor, co-founder and co-CEO, MinIO. “We’re changing that because we believe it can and should become the standard API for all analytical data and AI workloads. With the AIStor S3 Express API, pricing remains the same so enterprises can now put all of their analytical and AI data, not just a subset, in ‘express mode.’ This is drawing tremendous excitement from customers.”

“In most lakehouse environments, versioning is already handled by table formats like Apache Iceberg, which provide atomic operations at the file or table level,” said Sanjeev Mohan, principal analyst at SanjMo. “But when versioning is also enabled at the storage layer, it can create unnecessary duplication and complexity. Removing it from the storage layer simplifies the backend architecture, lowers CPU usage on storage servers, and helps prevent accidental storage growth and rising costs.”

AIStor’s S3 Express API support comes at no extra cost, without any request charges for GETs, PUTs and LISTs, and with key data protection and replication capabilities so it can be used for all enterprise analytical and AI data. Key features and benefits of the AIStor S3 Express API include:

  • Accelerated PUT and LIST operations: delivers up to 20% faster PUT operations, lowering CPU utilization, and up to 447% faster time-to-first-byte (TTFB) LIST operations relative to AIStor general purpose S3 API. This means faster training, faster analytics, and better infrastructure utilization.
  • New atomic, exclusive append operations: enables direct and safe object modification, eliminating multi-step update workflows. For example, media-broadcasting applications which add new video segments to video files can do so as they are transcoded and immediately streamed to viewers.
  • Full active/passive, disaster recovery (DR), and batch replication support: provides full performance benefits of the S3 Express API without loss of business continuity and disaster recovery (BC/DR). Synchronous replication means no data loss in the event of an outage and asynchronous replication enables data protection across the globe.
  • Streamlined and simplified API behavior: eliminates redundancies and implements simplifications and guardrails to improve the developer experience as well as application resiliency, predictability and security.

As the first and only on-premises and private cloud AI storage platform to adopt Amazon’s S3 Express API, MinIO is reinforcing its ongoing commitment to providing full and complete S3 API compatibility. To learn more about the AIStor S3 Express API, including the “how” and “why” behind specific features, please visit: https://blog.min.io/s3-express-api-added-to-aistor/. To book a demo, please visit min.io.

About MinIO
MinIO is the leader in high-performance object storage for AI. With 2B+ Docker downloads 50k+ stars on GitHub, MinIO is used by more than half of the Fortune 500 to achieve performance at scale at a fraction of the cost compared to the public cloud providers. MinIO AIStor is uniquely designed to meet the flexibility and exascale requirements of AI, empowering organizations to fully capitalize on existing AI investments and address emerging infrastructure challenges while delivering continuous business value. Founded in November 2014 by industry visionaries AB Periasamy and Garima Kapoor, MinIO is the world’s fastest growing object store.

Media Contact: Tucker Hallowell, Inkhouse, minio@inkhouse.com

NYSE Content Advisory: Pre-Market update + Nvidia, Salesforce beat on earnings

NEW YORK, May 29, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on May 29th

  • Stocks are rising Thursday after a federal court blocked President Trump’s reciprocal tariffs. Wednesday night, the U.S. Court of International Trade ruled that President Trump exceeded his authority when he enacted the tariffs.
  • Nvidia shares popped 5% in extended trading after the company beat earnings and sales estimates. Its data center business rose 73% from a year ago.
  • Salesforce (NYSE: CRM) exceeded earnings expectations and raised its guidance after reporting results. The company said it has agreed to pay $8 billion for data management software maker Informatica.

Opening Bell
First Eagle celebrates the launch of the FEGE & FEOE ETFs

Closing Bell
Xponential Fitness (NYSE: XPOF) celebrates its 2025 Analyst & Investor Fay

Click here to download the NYSE TV App

 

State Grid Gansu Linxia Power Supply Company: Special inspection of charging piles to safeguard green travel

LINXIA, China, May 29, 2025 /PRNewswire/ — Since May, Linxia Prefecture in Gansu Province, as a characteristic tourist destination in the northwest, has experienced a peak in tourist flow. In order to ensure the charging needs of new energy vehicles, on May 28, the State Grid Linxia Power Supply Company organized staff to conduct special inspections of the charging stations at the Guanghe County passenger station and the charging area at the Buyexiang service area, fully ensuring the smooth operation of green travel.

With the increasing popularity of attractions such as Linxia Prefecture’s tourism style line, Songmingyan, and Taizi Mountain, the number of self-driving tourists has surged, leading to a significant increase in charging demand. In response, the State Grid Linxia Power Supply Company has conducted a comprehensive inspection of key parts such as the charging pile wiring, charging gun interface, and display screen to eliminate potential hazards such as equipment overheating and aging lines, ensuring the efficient and stable operation of the charging piles.

In recent years, Linxia Prefecture has relied on its natural scenery and cultural landscapes to create a distinctive tourism brand. To this end, the State Grid Linxia Power Supply Company has optimized the distribution lines of charging stations in advance, upgraded the capacity of transformers, and used a digital monitoring platform to monitor the load of charging piles in real time, ensuring the safe and stable power supply of charging stations.

Grit Biotechnology Presents Clinical Breakthroughs at 2025 ASCO Annual Meeting

SHANGHAI, May 29, 2025 /PRNewswire/ — Grit Biotechnology Co., Ltd. (“Grit Bio“), a clinical-stage biotech pioneering novel immunotherapies announced today that three abstracts featuring new clinical data from tumor-infiltrating lymphocytes (TIL) therapies will be presented at the American Society of Clinical Oncology (ASCO) 42nd annual meeting, which is taking place in Chicago, IL from May 30th to June 3rd.

Grit Bio will provide the clinical updates of its leading TIL programs, including GT101 – an unmodified TIL therapy in treating recurrent and metastatic cervical cancer, GT201 – an armored TIL product expressing membrane bond IL-15 complex in treating various solid tumors, and GT300 – a CRISPR/Cas-edited dual KO TIL product in treating advanced solid tumors. The details of Grit Bio’s poster presentations are included below. The abstracts were published via the ASCO website on May 22, 2025.

  1. Title: GT101 autologous TIL therapy in patients with recurrent and metastatic cervical cancer: A phase 1 study.
    Presentation Type: Poster
    Time: 9:00 AM-12:00 PM CT, Sunday, June 1st
    Poster # 431
    Abstract #: 5533
  2. Title: Assessing the Safety and Efficacy of GT201: A First-in-Class Autologous Tumor-Infiltrating Lymphocyte Monotherapy in Advanced Solid Tumors
    Presentation Type: Poster
    Time: 9:00 AM-12:00 PM CT, Monday, June 2nd
    Poster #: 446
    Abstract #: 6038
  3. Title: Evaluating the Safety and Efficacy of CRISPR/Cas-Modified Tumor Infiltrating Lymphocytes (GT300) as Monotherapy in Advanced Solid Tumors
    Presentation Type: Poster
    Time: 9:00 AM-12:00 PM CT, Sunday, June 1st
    Poster #: 511
    Abstract #: 5613

“We have harnessed cutting-edge technologies, including advanced gene editing tools, to enhance the potency and persistence of our TIL products, enabling the development of multiple differentiated TIL pipelines.” said Dr. Yarong Liu, Founder and Chief Executive Officer of Grit Biotechnology. “These therapies have demonstrated promising clinical potential across a wide range of indications. Looking forward, we remain committed to accelerating their clinical advancement and actively seeking global collaborations to bring these transformative therapies to patients worldwide.”

About Grit Bio
GRIT Bio was founded in 2019 as an innovative biopharmaceutical company, focused on immune cell treatments for oncology and characterized by a R&D pipeline in TIL therapies. GRIT Bio has completed multiple rounds of equity financing and is backed by renowned venture capital funds. GT101, a proprietary injectable developed by GRIT Bio, is the first TIL therapy that entered registrational clinical trial. GT 101 is currently in pivotal Phase II clinical study. GRIT Bio’s GT201 injectable, the first TIL therapy with membrane-bound IL-15 complex, has cleared IND in both US and China. Core R&D platforms of the company include StemTexp® stemness TIL expansion platform, StaViral® stably virus transfected cell lines, ImmuT Finder® immune modulator target discovery platform, and KOReTIL® high-efficiency gene knock-out system. Based on the platforms, GRIT Bio generated a series of next-generation gene-edited TIL therapies. With internationally advanced technology reserve and industry resources, GRIT Bio aims to develop breakthrough therapies for solid tumors and bring new hope to cancer patients. For further information, please visit: www.grit-bio.com

Forward-Looking Statements
This press release contains forward-looking statements about Grit Biotechnology based on management’s current expectations, which are subject to known and unknown uncertainties and risks. Words such as “anticipated,” “expect,” “intend,” “plan,” “believe,” “seek,” “estimate,” “may,” “will,” and variations of these words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements regarding our expectations for our technology platforms, gene therapy candidates in development, collaborations, and plans for commercialization. Our actual results could differ materially from those discussed due to a number of factors, including, but not limited to, the risk inherent in developing pharmaceutical product candidates, conducting successful clinical trials, and obtaining regulatory approvals. Except as required by law, Grit Biotechnology assumes no obligation to update any forward-looking statements contained herein as a result of new information, future events, or otherwise.

Investor Contact: +86-21- 50828029, BD@grit-bio.com; Media Contact: +86-21- 50828029, PR@grit-bio.com

Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence

BOSTON, May 29, 2025 /PRNewswire/ — On May 20, Medicilon Preclinical Research (Shanghai) LLC (“Medicilon”) announces that it has successfully passed an on-site inspection by the FDA. The company receives an official Establishment Inspection Report (EIR) reaffirming its position as a trusted leader in preclinical R&D services .

A Milestone of Compliance and Capability 

The FDA inspection, conducted with meticulous detail, evaluated Medicilon’s organizational structure, personnel qualifications, SOPs, facilities integrity, documentation processes, experimental operations, quality assurance systems, and computerized infrastructures. Inspectors also reviewed several research projects submitted to the FDA.

FDA officials praised Medicilon for its scientific discipline and operational excellence, expressing anticipation for continued high-quality data submissions. This endorsement validated Medicilon’s enduring commitment to its guiding philosophy of “Quality First.”

Strategic Validation of Global R&D Impact

This is Medicilon’s first on-site FDA inspection in seven years, and the successful outcome significantly enhances its regulatory credibility. The milestone is a strong endorsement of its strategic vision, rooted in being “Innovation Driven, Quality Focused.”

By the end of 2024, Medicilon has helped 520 INDs enter clinical trials, through the approval of China’s NMPA, the US FDA, the EU EMA, the Australian TGA and the South Korean’s KFDA.  These INDs include innovative drugs in various fields, such as 34 antibodies, 28 ADC drugs, 8 GLP-1 drugs, 6 PROTAC drugs, 3 botanical drugs, etc. Looking ahead, Medicilon will remain committed to increasing investment in technological innovation and R&D, and is committed to launching more innovative and more high-quality technology and service solutions, embracing the broad opportunities and challenges of the global pharmaceutical market, and promoting the development of the global pharmaceutical industry!

About Medicilon

From its inception in 2004, Shanghai Medicilon Inc. (stock code: 688202.SH) has been committed to providing comprehensive R&D services to pharmaceutical companies, research institutions, and any organizations working in the preclinical space. By the end of 2024, Medicilon has provided drug development services to over 2,000 clients worldwide, and has been involved in the research and development of 520 new drugs and generic drug projects that have been approved for clinical trials with IND applications.

O-RAN ALLIANCE Global PlugFest Spring 2025 Demonstrated Steady Evolution of the O-RAN Ecosystem

  • O-RAN ALLIANCE Global PlugFests focus on testing and integration to accelerate the development of O-RAN based products and solutions
  • The O-RAN Global PlugFest Spring 2025 advanced O-RAN technology and procedures for testing, deployment and operation of carrier-grade networks
  • The PlugFest was co-hosted by 22 operators, OTICs, and academic and research institutions in 19 labs around the globe
  • A total of 69 companies and institutions participated, with some involved in multiple venues

BONN, Germany, May 29, 2025 /PRNewswire/ — The O-RAN ALLIANCE (O-RAN) today announced successful completion of the O-RAN ALLIANCE Global PlugFest Spring 2025.

O-RAN PlugFests are designed to accelerate the development of products and solutions based on O-RAN specifications by offering structured testing and integration opportunities in a neutral and collaborative environment.

At each O-RAN PlugFest, participants advance O-RAN-based technology and procedures for testing, deployment and operation of carrier-grade open, intelligent and virtualized Radio Access Networks (RAN).

Participants at the O-RAN Global PlugFest Spring 2025 demonstrated progress in diverse areas, including:

  • Automated, cloud-native RAN deployment & testing
  • AI-powered test automation with intelligent report analysis and automated test generation, enabled by Large Language Models (LLM)
  • Intelligent RAN energy savings of 25 to 30%, enabled by rApps on Non-Real-Time RAN Intelligent Controller (Non-RT RIC)
  • Intelligent network efficiency and service assurance, enabled by cell on-off switching rApp and xApp combined with traffic steering xApp
  • Integration of open-source O-RAN components from multiple open-source communities in O-RAN networks
  • Validation of transport network behavior under congestion and impairments for different deployment options
  • E2E network performance testing in various scenarios
  • Efficient cooperation enabling consistent and repeatable testing across labs and regions

O-RAN Global PlugFest Spring 2025 was hosted by 22 operators, Open Testing and Integration Centers (OTICs) and vendor-independent institutions. It took place in 8 venues and 19 labs around the world. It was conducted from February to May 2025 with a total of 69 participants, some of which participated at more than one venue.

“O-RAN Global PlugFests play a vital role in accelerating innovation built on O-RAN ALLIANCE specifications,” said Chih-Lin I, Co-chair of O-RAN ALLIANCE’s Technical Steering Committee and China Mobile Chief Scientist, Wireless Technologies, China Mobile Research Institute. “Each PlugFest showcases the steady evolution of the O-RAN ecosystem, highlighting progress across a wide range of technologies, solutions, and services that enhance RAN deployment and operations. It’s particularly encouraging to see that the progress of O-RAN intelligence and automation capabilities has been gaining momentum. A big thank you to all hosts, labs and participants for their great efforts.”

Participants in O-RAN ALLIANCE Global PlugFest Spring 2025

O-RAN ALLIANCE appreciates high interest from the community in testing and integration at the O-RAN Global PlugFest Spring 2025 and would like to recognize hosts, labs and participants, including:

Acentury, Airspan Networks, AT&T, Auray Technology, Battelle, CableLabs, Calnex Solutions, Capgemini Engineering, Deutsche Telekom, Digital Catapult, EANTC, Ericsson, EURECOM, Fujitsu, highstreet technologies, i14y Lab, Iowa State University, Juniper Networks, Keysight Technologies, Lenovo, LIONS Technology, LITE-ON Technology, Metanoia Communications, MTI, Nokia, North Carolina State University, Northeastern University, Nvidia, Pegatron, Quanta Cloud Technology (QCT), Rakuten Mobile, Rakuten Symphony, Rimedo Labs, Rohde & Schwarz, Rutgers University, Sera Network, Singapore University of Technology and Design (SUTD), Software Radio Systems, Supermicro, Telefonica, University of Utah, University of New Hampshire InterOperability Laboratory, University of Tokyo, Verizon, VIAVI Solutions, Virginia Polytechnical Institute and State University, Vodafone, VVDN Technologies, Wind River Systems, Xelera Technologies, YRP R&D Promotion Committee.

About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.

O-RAN ALLIANCE PlugFest
O-RAN ALLIANCE PlugFest

 

ETFs Unlock Growth in China’s Booming Tech Landscape

GUANGZHOU, China, May 29, 2025 /PRNewswire/ — In 2025, A-share tech-focused ETFs have continued to attract significant investor interests – the top five industry/thematic ETFs by net inflows, as of May 21, were all technology-related, collectively drawing in US$ 7.87 billion, including the E Fund CSI Artificial Intelligence ETF (159819), which saw a net inflow of US$ 1.17 billion. Meanwhile, leading asset managers in China are observed to actively positioning themselves in tech-focused ETFs, such as AI ETFs, robotics ETFs, and aviation ETFs. Notably, E Fund Management (“E Fund”), the largest mutual fund manager in China, has highlighted six cutting-edge sectors, spanning artificial intelligence, robotics & smart devices, computing technology, healthcare technology, energy technology and space technology and has established a complete range of ETF products to capture growth opportunities.

Six Cutting-edge Sectors Shaping the Future
Six Cutting-edge Sectors Shaping the Future

  1. Artificial Intelligence
    AI serves as the foundational infrastructure for emerging technologies. The E Fund CSI Artificial Intelligence ETF (159819) manages US$ 2.23 billion in assets, ranking first among its peers. Its underlying index, the CSI Artificial Intelligence Index, tracks 50 leading AI firms and emphasizes core technologies, with semiconductor companies, software developers, and computer equipment providers accounting for nearly 70% of its holdings.
  2. Robotics & Smart Devices
    Breakthroughs in humanoid robotics, such as their performances in world’s first humanoid robot half marathon and the RoboCup this year, have spurred market enthusiasm. The E Fund CNI Robot Industry ETF (159530) allocates over 50% of its weighting to humanoid robots, the highest proportion among all robotics-focused ETFs, after changes on index methodology taking effective on April 10.
  3. Computing Technology
    While robust computational power is critical for AI development, cloud computing emerged as a mainstream solution. The E Fund CSI Cloud Computing & Big Data ETF (516510), the largest ETF in its category tracking the same index, holds US$ 489 million in assets. It covers computing equipment, data centers, and cloud services, aligning with China’s push for digital infrastructure.
  4. Healthcare Technology
    Gene-editing technologies are poised to revolutionize treatments for genetic disorders and cancer. The E Fund CSI Biotechnology ETF (159837) invests in companies specializing in gene diagnostics, biopharmaceuticals, and advanced biomedical research, positioning it at the forefront of healthcare innovation.
  5. Energy Technology
    China leads global renewable energy innovation, particularly in photovoltaic installations, nuclear power, and solid-state battery storage. The E Fund CSI New Energy ETF (516090) provides exposure to lithium batteries, solar, wind, hydro, and nuclear energy, supporting the transition to clean power.
  6. Space Technology
    The successful launch of “Three-Body Computing Constellation” on May 15, which enables real-time data processing in orbit, marked a major step in China’s space technology. E Fund is set to launch a new ETF linked to the CNI General Aviation Index, tracking companies involved in aerospace materials, aircraft manufacturing, and flight operations.

Among them, the E Fund CSI Artificial Intelligence ETF (159819), the E Fund CSI Cloud Computing & Big Data ETF (516510), the E Fund CSI Biotechnology ETF (159837), and the E Fund CSI New Energy ETF (516090) are included in ETF Connect, empowering global investors to capitalize on China’s technology trends.

About E Fund

Established in 2001, E Fund Management Co., Ltd. (“E Fund”) is a leading comprehensive mutual fund manager in China with over RMB 3.5 trillion (USD 497 billion) under management.* It offers investment solutions to onshore and offshore clients, helping clients achieve long-term sustainable investment performances. E Fund’s clients include both individuals and institutions, ranging from central banks, sovereign wealth funds, social security funds, pension funds, insurance and reinsurance companies, to corporates and banks. Long-term oriented, it has been focusing on the investment management business since inception and believes in the power of in-depth research and time in investing. It is a pioneer and leading practitioner in responsible investments in China and is widely recognized as one of the most trusted and outstanding Chinese asset managers.

*Source: E Fund. AuM includes subsidiaries. Data as of March 31, 2025. FX rate is sourced from PBoC.